News | Research Suggests PDE5 Inhibitors May Improve Male Fertility
A recent BMJ study used two-sample Mendelian randomization to examine associations between genetically proxied phosphodiesterase 5 (PDE5) inhibition and male fertility, subjective well-being, and sexual behavior. PDE5 inhibitors commonly treat erectile dysfunction; the study explored their potential role in male fertility and overall health.
Background
Fertility rates are declining in many countries, and improved sexual function might help reverse the trend. PDE5 inhibitors such as vardenafil, sildenafil, avanafil, and tadalafil treat erectile dysfunction and pulmonary arterial hypertension. They inhibit PDE5 and increase cyclic guanosine monophosphate (cGMP), relaxing vascular smooth muscle and improving blood flow. Their long-term effects, especially on male fertility and well-being, remain insufficiently studied.
Methods
The study analyzed genome-wide association data from European men, focusing on the effects of PDE5 inhibition on fertility, sexual behavior, and subjective well-being. Mendelian randomization used genetic variants to predict random allocation of specific traits and reduce biases found in observational studies.
Results
Researchers identified five genetic variants that may inhibit PDE5. Genetically proxied PDE5 inhibition was associated with 0.3 more children among men, but no such association was found among women. No significant association was found with the number of male sexual partners, probability of sexual activity, or subjective well-being.
Although PDE5 inhibitors may improve fertility in men with erectile dysfunction, misuse can cause adverse effects such as vision loss, hypotension, and erections at inappropriate times. Further research is needed to confirm the findings and prevent misuse.
Conclusion
The study offers a new perspective on the potential of PDE5 inhibitors to improve male fertility and overall health, but further research is needed to confirm the results and assess their clinical significance. Men with erectile dysfunction may experience some fertility benefit, but the medicines should be used cautiously.
News | Research Suggests PDE5 Inhibitors May Improve Male Fertility
News | Research Suggests PDE5 Inhibitors May Improve Male Fertility
A recent BMJ study used two-sample Mendelian randomization to examine associations between genetically proxied phosphodiesterase 5 (PDE5) inhibition and male fertility, subjective well-being, and sexual behavior. PDE5 inhibitors commonly treat erectile dysfunction; the study explored their potential role in male fertility and overall health.
Background
Fertility rates are declining in many countries, and improved sexual function might help reverse the trend. PDE5 inhibitors such as vardenafil, sildenafil, avanafil, and tadalafil treat erectile dysfunction and pulmonary arterial hypertension. They inhibit PDE5 and increase cyclic guanosine monophosphate (cGMP), relaxing vascular smooth muscle and improving blood flow. Their long-term effects, especially on male fertility and well-being, remain insufficiently studied.
Methods
The study analyzed genome-wide association data from European men, focusing on the effects of PDE5 inhibition on fertility, sexual behavior, and subjective well-being. Mendelian randomization used genetic variants to predict random allocation of specific traits and reduce biases found in observational studies.
Results
Researchers identified five genetic variants that may inhibit PDE5. Genetically proxied PDE5 inhibition was associated with 0.3 more children among men, but no such association was found among women. No significant association was found with the number of male sexual partners, probability of sexual activity, or subjective well-being.
Although PDE5 inhibitors may improve fertility in men with erectile dysfunction, misuse can cause adverse effects such as vision loss, hypotension, and erections at inappropriate times. Further research is needed to confirm the findings and prevent misuse.
Conclusion
The study offers a new perspective on the potential of PDE5 inhibitors to improve male fertility and overall health, but further research is needed to confirm the results and assess their clinical significance. Men with erectile dysfunction may experience some fertility benefit, but the medicines should be used cautiously.
Source:
Collected online